Cytokines and Estrogen in Bone: Anti-Osteoporotic Effects
- 30 April 1993
- journal article
- review article
- Published by American Association for the Advancement of Science (AAAS) in Science
- Vol. 260 (5108), 626-627
- https://doi.org/10.1126/science.8480174
Abstract
No abstract availableThis publication has 18 references indexed in Scilit:
- Increased Osteoclast Development After Estrogen Loss: Mediation by Interleukin-6Science, 1992
- Production of various cytokines by normal human osteoblast-like cells in response to interleukin-1 beta and tumor necrosis factor-alpha: lack of regulation by 17 beta-estradiolEndocrinology, 1992
- 17 beta-estradiol inhibits interleukin-6 production by bone marrow-derived stromal cells and osteoblasts in vitro: a potential mechanism for the antiosteoporotic effect of estrogens.Journal of Clinical Investigation, 1992
- Oestrogen Receptors in MacrophagesScandinavian Journal of Immunology, 1990
- Parathyroid hormone (PTH) and PTH-like protein (PLP) stimulate interleukin-6 production by osteogenic cells: A possible role of interleukin-6 in osteoclastogenesisBiochemical and Biophysical Research Communications, 1989
- Parathyroid hormone and lipopolysaccharide induce murine osteoblast-like cells to secrete a cytokine indistinguishable from granulocyte-macrophage colony-stimulating factor.Journal of Clinical Investigation, 1989
- Evidence of Estrogen Receptors in Normal Human Osteoblast-Like CellsScience, 1988
- Estrogen Binding, Receptor mRNA, and Biologic Response in Osteoblast-Like Osteosarcoma CellsScience, 1988
- Stimulation of bone resorption and inhibition of bone formation in vitro by human tumour necrosis factorsNature, 1986
- An interleukin 1 like factor stimulates bone resorption in vitroNature, 1983